Paul Sequeira came to Newry in 2015 from Thermalin Diabetes, a Cleveland biotech startup, where he was involved in new product development and supported efforts to secure venture capital funding. As a Newry consultant, Paul has led engagements in markets ranging from automotive to semiconductors, and many of his recent projects have focused on the life sciences and medical spaces. He has developed the commercialization strategy for a consumer healthcare product, initiated customer engagement for a novel bio-agricultural technology, and identified and evaluated dozens of opportunities for engineered materials, including technical analyses and go-to-market strategies.
Paul has a Master’s in biochemistry from Case Western Reserve University with a focus on the evolution of gene regulatory networks. You can read more of Paul’s thoughts on the intersection of innovation and evolutionary biology here.